Biomatz
Seoul
About Biomatz
Biomatz is a biotechnology company specializing in microbiome therapeutics. Their proprietary platform designs cooperative microbial consortia by isolating and analyzing complex gut microbiota interactions, facilitating the development of live biotherapeutic products. It aims to advance personalized medicine and gut health solutions with applications spanning pharmaceuticals, nutraceuticals, and functional foods.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Seed (Jun 2023)
- Website: biomatz.com
- Phone: +82-2-6257-9240
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biomatz-137223 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.